Announcements Trials
Browse Landscape

Status

Completed 6Unknown 3Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 144Observational 6

Sponsor

Cancer Type

Gynecologic 4Breast 2

Conditions

Ovarian Neoplasms 3Breast Neoplasms 2Ovarian Epithelial Cancer Recurrent 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 59Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Bevacizumab 40Reverse Transcriptase Polymerase Chain Reaction 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Hepatectomy 25Therapeutics 24Neoadjuvant Therapy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Observational × liposomal doxorubicin × Clear all
NCT02394015 2020-03-27

RETRO-ROC

Grupo Español de Investigación en Cáncer de Ovario

Completed
90 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

NCT04258163 2020-02-10

Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Completed
760 enrolled
Breast

Breast Neoplasms

NCT03562533 2019-02-28

Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer

Konkuk University Medical Center

Completed
432 enrolled
Gynecologic

Ovarian Neoplasms

NCT03367182 2019-01-11

REBECA

Yonsei University

Completed
50 enrolled
Gynecologic

Ovarian Neoplasms

NCT00743431 2015-04-15

Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED)

Merck Sharp & Dohme LLC

Completed
224 enrolled 6 charts
Gynecologic

Ovarian Neoplasms

NCT00736333 2014-11-05

A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)

Merck Sharp & Dohme LLC

Completed
167 enrolled 10 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡